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ABSTRACT 
 
Clostridium perfringens enterotoxin (CPE)- producing C. perfringens type A is considered 
one of the most common causes of food poisonings in the industrialized world. CPE-
producing C. perfringens type A is also involved in antibiotic-associated diarrhea and 
sporadic diarrhea in humans as well as in animals. C. perfringens is widely dispersed, but 
enterotoxin gene-carrying (cpe-positive) isolates are rarely found in nature. Thus, not much is 
known about reservoirs or transmission routes of this pathogen. This work aimed to improve 
diagnostics of cpe-positive C. perfringens by developing a method for the detection and 
isolation of cpe-positive C. perfringens type A. Other objectives were to improve 
identification and typing of C. perfringens. With novel assays, molecular epidemiology of 
cpe-positive C. perfringens type A was further investigated. 
 
Development of the hydrophobic grid membrane filter-colony hybridization (HGMF-CH) 
method for the detection and isolation of cpe-positive C. perfringens from feces has provided 
an effective tool since none of the previously reported detection methods have facilitated the 
isolation of cpe-positive C. perfringens. The main advantage of the HGMF-CH method is that 
it allows the detection and isolation of cpe-positive colonies among large numbers of cpe-
negative isolates. Thus, the method is unaffected by the presence of cpe-negative C. 
perfringens in samples, a frequent problem when screening cpe-positive C. perfringens from 
nature. Use of the HGMF-CH method in a subsequent study proved that the method is 
adequate for the detection and isolation of cpe-positive C. perfringens from fecal samples. By 
initially screening samples for the presence of cpe and by choosing polymerase chain reaction 
(PCR)-positive samples for HGMF-CH, costs are reduced and the method is rendered even 
more effective. 
 
To obtain a tool for toxinotyping C. perfringens isolates and determining the presence of cpe 
in these isolates, a multiplex PCR assay was established. The novel assay was established by 
designing new cpa primers and combining them with cpb, etx, iA, and cpe primers from a 
previously published protocol. The novel assay amplified all PCR products simultaneously 
and was used for the investigation of 118 C. perfringens isolates. The assay was also used in 
subsequent studies for toxinotyping and determining the presence of cpe in C. perfringens 
isolates. 
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The amplified fragment length polymorphism (AFLP) protocol provides a highly 
reproducible, easy-to-perform, and relatively
 
fast method for the identification and DNA 
fingerprinting of C. perfringens. This assay overcomes the problems of extracellular DNase 
production, which are occasionally present with other typing methods. 
 
When investigating the presence of cpe-positive C. perfringens in the feces of healthy food- 
handlers, the organism was carried by 18% of the individuals. The presence of strains 
representing all previously identified genotypes (plasmid-borne IS1151-cpe, plasmid-borne 
IS1470-like-cpe, and chromosomal IS1470-cpe) as well as strains carrying previously 
unrecognized genetic arrangements attached to cpe shows that various different 
subpopulations of cpe-positive C. perfringens type A occur in the human gastrointestinal tract 
and that the healthy human is a rich reservoir for cpe-positive C. perfringens type A. 
Additionally, pulsed-field gel electrophoresis (PFGE) typing of the strains revealed a loss or 
acquisition of the cpe plasmid by C. perfringens strains. Thus, our findings support the theory 
of the movable nature of cpe. Overall, the common occurrence of cpe-positive C. perfringens 
type A in the feces of healthy food-handlers and the full capacity of these strains to produce 
CPE indicate that humans handling food should be considered a possible source of 
contamination of food. 
 
By showing that 25% of European C. perfringens type A food poisoning outbreaks are caused 
by strains carrying plasmid-borne cpe, we reveal that the generally accepted relationship 
between cpe genotype and CPE-associated gastrointestinal diseases is not straightforward and 
that plasmid-borne cpe is a common cause of food poisonings. 
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1. INTRODUCTION 
 
Clostridium perfringens is thought to be the most widely dispersed pathogen on earth (Canard 
et al. 1992). The presence of C. perfringens DNA fragments in the colon of "Tyrolean 
Iceman", the mummy discovered in an Alpine glacier, is evidence that C. perfringens and 
humans have coexisted for at least 5000 years (Cano 2000). However, the first report of 
C. perfringens dates back to 1891, when Doctor Welch and his colleagues found a previously 
unknown bacterium forming gas bubbles in an autopsied patient's blood vessels and 
christened the bacterium Bacillus aerogenes capsulatus (Welch and Nuttall 1892). The 
organism became known as Bacillus welchii. Several other names, i.e. Bacillus enteritidis 
sporogenes, Bacillus perfringens, Bacterium welchii, and Clostridium welchii, were also used 
(Andrewes 1899, Cato et al. 1986). During World War I, the organism was recognized as an 
important cause of gas gangrene in battlefield
 
injuries, killing hundreds of thousands of 
soldiers (Shimizu et al. 2002). Later, the organism became known as Clostridium perfringens 
(i.e. a small spindle, “breaking through”) (Skerman et al. 1980). 
 
Today, C. perfringens has a notorious reputation for possessing an extremely wide toxin 
arsenal, with over 15 toxins. The organism is therefore capable of producing different 
pathological pictures and causing numerous different histotoxic and enteric diseases in both 
humans and animals (Smedley et al. 2004). 
 
C. perfringens type A was first identified as a cause of food poisoning in the 1940s (Knox and 
MacDonald 1943, McClung 1945). C. perfringens type A food poisoning ranks annually as 
one of the most common food poisonings in the industrialized world (Mead et al. 1999, Adak 
et al. 2002, Hatakka and Pakkala 2003). In addition to food poisoning, Clostridium 
perfringens enterotoxin (CPE)-producing C. perfringens type A causes antibiotic-associated 
diarrhea and sporadic diarrhea in humans and animals. 
 
The ubiquitous distribution of C. perfringens has earlier been considered a logical explanation 
for the common occurrence of C. perfringens type A food poisonings. Therefore, all C. 
perfringens isolates were regarded as potential causative agents for C. perfringens type A 
food poisonings. However, currently we know that only a small minority, less than 5%  of 
global C. perfringens isolates produce CPE and are thus capable of causing food poisonings 
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(Smedley et al. 2004). Recent findings of the variable loci (plasmid vs. chromosome) and 
different genetic arrangements adjacent to cpe have shown that cpe-positive isolates form in 
different subpopulations. These subpopulations are responsible for different CPE-associated 
diseases, i.e. chromosomal cpe-bearing strains are involved in food poisonings, whereas 
strains carrying cpe in the plasmid are typical in antibiotic-associated or sporadic diarrhea 
cases as well as in animal diarrheas (Cornillot et al. 1995, Katayama et al. 1996, Collie and 
McClane 1998, Sparks et al. 2001). This indicates that different subpopulations of cpe-
positive C. perfringens may have different epidemiologies. However, not much is known 
about the molecular epidemiology of cpe-positive C. perfringens, and the reservoirs and 
transmission routes have remained unidentified. This is partly due to methodological 
problems since conventional culture methods do not distinguish cpe-positive C. perfringens 
from cpe-negative C. perfringens, which usually dominate in natural samples.  
 
This work aimed to develop a specific method for the detection and isolation of cpe-positive 
C. perfringens and to identify potential reservoirs for cpe-positive C. perfringens by using this 
method. The epidemiology of different genotypes of cpe-positive C. perfringens in food 
poisoning outbreaks was also elucidated. A further objective was to improve diagnostics of C. 
perfringens by harnessing amplified fragment length polymorphism (AFLP) as well as 
multiplex polymerase chain reaction (PCR) in typing and identifying C. perfringens isolates. 
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2. REVIEW OF THE LITERATURE 
 
2.1 Clostridium perfringens 
2.1.1 Classification and characteristics 
 
Clostridium perfringens is a Gram-positive, catalase-negative, nonmotile, endospore-forming 
bacterium with a cell size of 0.6-2.4 × 1.3-19.0 µm (Cato et al. 1986). The spores are 
subterminal and oval. C. perfringens is a typical member of the genus Clostridium, requiring 
anaerobic conditions for growth. However, contrary to other clostridia, C. perfringens 
tolerates moderate exposure to air and requires only a relatively modest reduction in 
oxidation-reduction potential (Eh) for growth (Cato et al. 1986). C. perfringens is known as 
the most rapidly multiplying organism, with some strains possessing less than a 10-minute 
doubling time (Willardsen et al. 1978, Willardsen et al. 1979). The organism is divided into 
five types (A through E) according to the production of the major lethal toxins alpha, beta, 
epsilon, and iota (Brooks et al. 1957, Sterne and Warrack 1964) (Table 1). 
 
Table 1. Typing of Clostridium perfringens. 
 
Type 
 
 
Toxin(s) produced 
  
Alpha 
 
 
Beta 
 
Epsilon 
 
Iota 
 
 
A 
 
+ 
 
- 
 
- 
 
- 
B + + + - 
C + + - - 
D + - + - 
E + - - + 
 
 
C. perfringens was the first Gram-positive bacterium for which a complete genome map was 
constructed by using pulsed-field gel electrophoresis (PFGE) (Canard and Cole 1989). The 
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genome size of C. perfringens varies between 3.0 and 3.7 Mb (Rood 1997, Shimizu et al. 
2001) and the GC content of DNA is 24-27% (Cato et al. 1986). Currently, the entire genome 
sequence of three different C. perfringens strains has been published (Shimizu et al. 2002, 
Myers et al. 2006). Comparison of sequences has revealed an unexpected degree of genomic 
variability between C. perfringens strains, with discrete islands
 
containing genes coding for 
mobile elements, metabolic capabilities, extracellular
 
capsules, toxins, and other enzymes, 
enabling C. perfringens to adapt to different environmental conditions and to possess different 
disease phenotypes and
 
virulence characteristics (Myers et al. 2006). 
 
2.1.2 Microbial ecology 
 
C. perfringens is referred to as the most widely distributed pathogenic microorganism in 
nature (Cato et al. 1986). Its principal habitats are soil and the intestinal contents of humans 
and animals (Smith 1975, Yamagishi et al. 1976, Brant et al. 1978). C. perfringens is also 
present in marine sediments and sewage (Smith 1975, Lisle et al. 2004). Type A 
predominates in the environment and human intestines, whereas types B-E are usually carried 
by animals (Smith 1975). In potable water, the presence of C. perfringens is often used as an 
indicator of long-term fecal contamination (Edberg et al. 1997, Hörman et al. 2004). The 
organism also gains easy access to different foods and spices (Ladiges et al. 1974, Foster et 
al. 1977, Smart et al. 1979, Aguilera et al. 2005). Growth characteristics of C. perfringens are 
described in Table 2. 
 
Table 2. Growth characteristics of Clostridium perfringens. 
  
Minimum 
 
Optimum 
 
Maximum 
 
Reference 
 
Temperature (ºC) 
 
10-12 
 
43-47 
 
50-55 
 
(Labbé 2000, Li and McClane 2006a) 
pH 5.0-5.5 6.0-7.2 8.0-9.0 (Labbé 2000) 
NaCl (%) - 5.0-8.0
a 
- (Labbé 2000, Li and McClane 2006a) 
NaNO3 (ppm) - 60-2560
a 
- (Labbé 2000, Li and McClane 2006a) 
Water activity (aw) 0.93 0.95-0.96 0.97 (Labbé 2000) 
a
 Concentration/amount limiting the growth of Clostridium  perfringens in different foods. 
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2.1.3 Diseases caused by Clostridium perfringens 
 
Due to the remarkably wide toxin arsenal of more than 15 toxins, C. perfringens is able to 
cause several different enteric and histotoxic diseases in both humans and animals (Table 3). 
The nomination of C. perfringens epsilon toxin to the U.S. bioterrorism selected agent list 
illustrates the potency of C. perfringens toxins (Khan et al. 2000). The organism is divided 
into five types (A through E) according to the production of the major toxins alpha, beta, 
epsilon, and iota (Table 1). In addition, C. perfringens isolates may produce other toxins such 
as enterotoxin (CPE) and beta2 toxin (Gibert et al. 1997, Smedley et al. 2004). The 
pathogenicity of C. perfringens is attributed to different types (Brooks et al. 1957, Sterne and 
Warrack 1964) (Table 3). However, rather than being a function of a single toxin, the 
virulence of different C. perfringens isolates is considered a multifactorial trait, with different 
determinants contributing to adaptation of the organism to its niche and to producing the 
pathological picture (Canard et al. 1992, Miyamoto et al. 2006, Sawires and Songer 2006, 
Sayeed et al. 2007). The virulence of C. perfringens has not yet been fully elucidated. 
 
Table 3. Diseases associated with Clostridium perfringens (Hatheway 1990, Songer 1996, Petit et al. 1999, 
Smedley et al. 2004, Fisher 2006). 
 
 
Type 
 
Disease(s) 
 
 
Humans 
 
 
Animals 
A Food poisoning
a 
Antibiotic-associated diarrhea
a 
Sporadic diarrhea
a 
Sudden infant death syndrome
a 
Gas gangrene 
Acute gastric dilatation 
Necrotic enteritis (infants) 
 
Enterotoxemia (various animals) 
Necrotic enteritis (fowl) 
Intestinal clostridiosis (equine) 
Acute gastric dilatation (various animals) 
Enteritis (various animals)
a 
B  Enterotoxemia (sheep, goat, guinea pig) 
Dysentery (lamb) 
 
C Enteritis necroticans  
(i.e. Darmbrand or pigbel) 
Enterotoxemia (lamb and pig) 
Struck (sheep) 
Necrotic enteritis (fowl) 
Enteritis (porcine) 
 
D  Enterotoxemia (sheep) 
Pulpy kidney disease (lamb) 
 
E  Enterotoxemia (calf, guinea pig, rabbit) 
Dysentery (lamb) 
a
 Enterotoxin-producing strains associated with the disease. 
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2.2 Clostridium perfringens enterotoxin (CPE) 
2.2.1 Characteristics of CPE 
 
When C. perfringens was discovered as a cause of food poisonings, the strains were proposed 
to produce an enterotoxin (McClung 1945). At a later date, this toxin, characterized to be a 
35–kDa single polypeptide with an isoelectric point of 4.3, was named C. perfringens 
enterotoxin (CPE) (Hauschild and Hilsheimer 1971, Stark and Duncan 1972). CPE is stabile 
at a pH between 5 and 12 and is inactivated with pronase, but not with trypsin, lipase, or 
amylase (Duncan and Strong 1969). The enteric pathogenicity of CPE has been evidenced in 
human volunteer feeding studies, showing that purified toxin causes diarrhea and cramping 
(Skjelkvale and Uemura 1977). Animal model studies with isogenic enterotoxin gene mutant 
have further confirmed Koch’s molecular postulates about the requirement of CPE expression 
to cause gastrointestinal (GI) effects (Sarker et al. 1999). 
 
2.2.2 Enterotoxin gene (cpe) 
 
The gene coding for enterotoxin (cpe) has been cloned and sequenced in fragments (Hanna et 
al. 1989, Iwanejko et al. 1989, Van Damme-Jongsten et al. 1989) and in its entity (Czeczulin 
et al. 1993). cpe-carrying (cpe-positive) isolates possess a single copy of cpe (Cornillot et al. 
1995). The gene is homologous in all cpe-positive C. perfringens strains studied, but 45-bp 
insertions have been found in the cpe promoter region in some strains (Melville et al. 1994). 
No considerable DNA sequence homology with other organisms has been observed (Petit et 
al. 1999). Although in CPE-associated diseases C. perfringens isolates usually represent type 
A, cpe can be detected in C. perfringens isolates representing any type (A-E). Not all isolates 
are, however capable of expressing the gene product. cpe-positive C. perfringens type E 
isolates, for example, possess mutations in an open reading frame (ORF), promoter(s), and the 
ribosome binding site of their cpe sequences and therefore do not produce CPE (Billington et 
al. 1998). However, in CPE-associated diseases, the isolate usually represents type A, perhaps 
because isolates of type A account for more than 95% of global C. perfringens isolates 
(McClane 2001). 
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cpe-positive C. perfringens type A strains possess cpe in either a chromosome or a large 
plasmid (Canard et al. 1992, Cornillot et al. 1995) (Fig. 1). Chromosomal cpe-bearing strains 
are involved in food poisonings, whereas strains carrying cpe in a plasmid are typically 
present in antibiotic-associated or sporadic diarrhea cases as well as in animal diarrheas 
(Cornillot et al. 1995, Katayama et al. 1996, Collie and McClane 1998, Sparks et al. 2001). In 
both cases, insertion sequence (IS) elements have been found adjacent to cpe, indicating that 
cpe is movable (Brynestad et al. 1994, Cornillot et al. 1995, Brynestad 1997, Brynestad et al. 
1997, Brynestad et al. 1999, Miyamoto et al. 2002). In strains with cpe in the chromosome 
(chromosomal cpe strains), cpe is located on a 6.3-kb transposable element, named Tn5565 
(Brynestad et al. 1997, Brynestad et al. 1999). This apparent transposon includes two copies 
of IS1470 on both sides (up- and downstream) of cpe (Brynestad et al. 1997) and may have 
circular intermediate forms (Brynestad et al. 1999). A few papers have reported a loss of cpe 
from chromosomal strains under laboratory conditions, but the actual movement of Tn5565 
has not been demonstrated (Collie and McClane 1998, Ridell et al. 1998). 
 
In cpe-positive strains with cpe in the plasmid (plasmid-borne cpe strains), cpe is also closely 
associated with IS elements. Some plasmid-borne cpe strains possess sequences homologous 
to IS1470 downstream of cpe (Miyamoto et al. 2002) (Fig. 1). These sequences reside in 
about the same position, but are oppositely oriented and defective relative to the IS1470 
sequences found in chromosomal cpe. The other plasmid-borne cpe strains contain an IS1151 
sequence downstream from cpe (Fig. 1). cpe plasmid with IS1470-like sequences has been 
shown in vitro to be transferable via conjugation to cpe-negative C. perfringens type A strains 
(Brynestad et al. 2001). 
 
In addition, all currently investigated cpe-positive type A isolates contain IS1469 about 1.2 kb 
upstream of cpe, and plasmid-borne cpe type A strains possess an ORF potentially encoding 
cytosine methylase (dcm) upstream of IS1469 (Miyamoto et al. 2002) (Fig. 1). Similar dcm 
sequences have also been detected in several cpe-negative C. perfringens isolates carrying 
plasmids, but not in type A isolates carrying a chromosomal cpe (Miyamoto et al. 2002) (Fig. 
1). 
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Figure 1. Location of different insertion sequence (IS) elements in relation to the location of cpe in cpe-positive 
Clostridium perfringens type A isolates. A, plasmid-borne cpe genotype IS1151-cpe; B, plasmid-borne cpe 
genotype IS1470-like-cpe; C, chromosomal genotype IS1470-cpe (Brynestad 1997, Miyamoto et al. 2002). 
 
2.2.3 Sporulation and production of CPE 
 
Spore formation is a trait of certain bacteria, including Bacilli and Clostridia, to survive under 
such unfavorable conditions imposed by heat, chemicals, radiation, or starvation (Stephenson 
and Lewis 2005). Spores are metabolically inactive and may survive for long periods, 
eventually resuming vegetative cell growth when appropriate conditions are present 
(Stephenson and Lewis 2005). Sporulation mechanisms have been extensively studied, but 
specific signals triggering C. perfringens sporulation are not well understood (Huang 2007).  
 
On the genetic level, the initiation
 
of sporulation is controlled by the sporulation transcription 
factor spo0A (Burbulys et al. 1991, Brown et al. 1994, Huang and Sarker 2006). Recently, it 
has been suggested that inorganic phosphate may serve as an important signal required for 
spore formation of C. perfringens (Philippe et al. 2006).  
 
CPE biosynthesis is temporally associcated with sporulation (Duncan et al. 1972, Duncan 
1973, Garcia-Alvarado et al. 1992, Czeczulin et al. 1996). CPE synthesis begins after the 
induction of sporulation and increases progressively for at least 6-8 hours (Smith and 
McDonel 1980, Melville et al. 1994). CPE is not secreted, but accumulates in the cytoplasm, 
and is localized occasionally in paracrystalline inclusion bodies (Duncan et al. 1973). CPE 
may represent up to 15-30% of the total protein present in the cell (Labbé 1981, Czeczulin et 
al. 1993, Melville et al. 1997). The toxin is released into the intestinal lumen when 
sporulation is completed and the mother cell lysed, releasing a mature spore (Duncan 1973). 
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The association between sporulation and CPE production has been evidenced also at the 
genetic level since inactivation of spo0A from a cpe-positive C. perfringens type A strain was 
shown to block not only sporulation but also CPE production (Huang et al. 2004). 
 
2.2.4 Mechanism of action of CPE 
 
Intestinal activity of CPE has been demonstrated in various animals (Duncan et al. 1968, 
Hauschild et al. 1970, Hauschild et al. 1971, Niilo and Dorward 1971, Bartlett et al. 1972, 
McDonel 1974, McDonel and Duncan 1975). Early studies showed that shortening of 
intestinal villi and desquamation of intestinal epithelium cause diarrheic symptoms (McDonel 
et al. 1978, Sherman et al. 1994). In vitro studies in the human ileum have revealed that CPE 
induces significant morphological damage and transport changes (Fernández-Miyakawa et al. 
2005). Moreover, slight changes in the human colon have been seen after exposure to CPE 
(Fernández-Miyakawa et al. 2005). Intravenously administered CPE has been shown to be 
lethal for several animals (Niilo 1973, Siarakas et al. 1995).  
 
On the cellular and molecular level, CPE inserts itself into the plasma membrane of 
enterocytes and forms a small complex of ~90 kDa with claudin-3 and claudin-4 receptors 
(Katahira et al. 1997a, Katahira et al. 1997b, Fujita et al. 2000, Smedley and McClane 2004). 
After forming the small complex with the receptor, CPE localizes to a larger, SDS-resistant 
complex (~155 kDa). This large complex initiates membrane permeability alterations, leading 
to calcium influx into the cell. Depending on the amount of CPE, cellular levels of calcium 
increase rapidly, and the cell dies via either the apoptotic or the oncotic pathway (Smedley 
and McClane 2004). 
 
2.2.5 CPE-associated diseases 
 
Food poisoning  
 
C. perfringens type A is reported to be one of the most common causes of food poisonings 
throughout the industrialized world (Mead et al. 1999, Adak et al. 2002, Brynestad and 
Granum 2002, Lukinmaa et al. 2002, Hatakka and Pakkala 2003). The symptoms are caused 
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by CPE, and although other types of C. perfringens may also produce CPE, most (if not all) of 
these food poisoning cases are caused by C. perfringens type A strains (McClane 2001). 
 
C. perfringens type A food poisoning outbreaks are usually reported in institutionalized 
settings and involve large numbers of victims (Lund et al. 2000). Temperature abuse of the 
food is considered the major contributing factor to this food poisoning, with the most 
common vehicle being meat or poultry. Optimal conditions for food poisonings arise when 
contaminated food is held or served at a temperature range of 10-54°C, allowing growth of 
the organism. When large numbers of vegetative cells are subsequently ingested, they 
sporulate and release CPE into the intestinal lumen (McClane 2001). As a consequence of 
this, severe abdominal cramps and diarrhea occur within 8-12 hours, usually with a 
spontaneous recovery within 24 hours. Fatalities are rare but possible in elderly or debilitated 
persons (Smith 1998, Bos et al. 2005). 
 
Recommended laboratory criteria used in association with clinical presentation and 
epidemiological evidence to implicate C.
 
perfringens in foodborne disease are as follows: 
high numbers of viable cells (>10
5
/g) in suspect foods, presence of elevated fecal spore counts 
(>10
6
/g), presence of the same serotype in all individuals in an outbreak, or demonstration of 
the same serotype of C. perfringens in both contaminated food and feces (Hauschild 1975, 
NCFA 1995, Lund et al. 2000). Notably, these widely used laboratory criteria do not involve 
the detection of CPE production or the presence of cpe gene in foods or feces, or in the 
suspected C. perfringens isolate. This is definitely a weakness since not all C. perfringens 
isolates present in food or feces produce CPE and are thus capable of causing food 
poisonings. Nor do traditionally used laboratory criteria involve molecular typing methods to 
determine the clonality of C. perfringens isolates related to the food poisoning outbreak. 
 
Antibiotic-associated diarrhea and sporadic diarrhea 
 
CPE-producing C. perfringens type A has also been implicated as a cause of up to 15% of 
antibiotic-associated diarrheas (AADs) and sporadic diarrheas (SDs) in humans (Borriello et 
al. 1984, Borriello et al. 1985, Jackson et al. 1986b, Brett et al. 1992, Mpamugo et al. 1995, 
Abrahao et al. 2001, Modi and Wilcox 2001, Asha and Wilcox 2002, Carney et al. 2002, 
Heimesaat et al. 2005, Joshy et al. 2006a, Joshy et al. 2006b). AADs develop after exposure 
to such antibiotic as penicillin, cephalosporins, trimethoprim, or cotrimoxazole (Borriello 
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1985, Borriello et al. 1985, Jackson et al. 1986b, Brett et al. 1992, Borriello 1995, Mpamugo 
et al. 1995, Modi and Wilcox 2001, Asha and Wilcox 2002, Ackermann et al. 2005). The 
symptoms involve watery and/or bloody diarrhea that can last for several weeks or months 
(Modi and Wilcox 2001). Relapses are also common (Borriello et al. 1984, Modi and Wilcox 
2001). Risk factors are use of a nasogastric tube or proton pump inhibitors and older age of 
the patient (Asha et al. 2006). C. perfringens type A SD is suspected when a patient develops 
the disease without prior exposure to antibiotics (Wada et al. 1996). 
 
The pathogenesis of AAD and SD caused by cpe-positive C. perfringens type A is not fully 
understood. In contrast to the massive numbers of cpe-positive cells ingested during C. 
perfringens type A food poisoning, AAD or SD is thought to be caused by a small inoculum 
of cpe-positive cells (Smedley et al. 2004). In vivo conjugative transfer of the cpe plasmid to 
normal intestinal
 
flora isolates of C. perfringens has been suggested to be important in 
establishing
 
C. perfringens type A AAD or SD. Small numbers of cpe-positive cells could 
transfer the cpe plasmid to the formerly cpe-negative C. perfringens strains that are already 
adapted for intestinal
 
colonization and growth. This in vivo conversion would thus hasten
 
disease onset and may even be required to reach the in vivo levels
 
of cpe-positive 
C. perfringens cells necessary for initiating
 
enteric
 
disease (Brynestad et al. 2001). 
Conjugative transfer of cpe plasmid has been evidenced in vitro, but not yet in vivo 
(Brynestad et al. 2001). It is not known, whether these plasmid cpe-carrying C. perfringens 
type A strains are normally present in the GI tract or whether they are acquired just prior to 
disease onset. Clostridium perfringens beta2 toxin possibly acts as an accessory toxin in AAD 
and SD caused by cpe-positive C. perfringens type A (Fisher 2006).  
 
Sudden infant death syndrome 
 
Sudden infant death syndrome (SIDS) continues to account for large numbers of unexpected 
infant deaths in many countries, being considered a complex, multifactorial disorder affected 
by genetic, developmental, and environmental factors (Hunt and Hauck 2006). Bacterial 
toxins, such as Clostridium perfringens enterotoxin (CPE), have been proposed to play a role 
in SIDS (Murrell et al. 1987, Lindsay et al. 1993, Das 2002, Blackwell et al. 2005, Kamaras 
et al. 2001a, Kamaras et al. 2001b). Intestinal production and systemic absorption of CPE 
have been suggested to result in rapid death in SIDS, whereas in enteric diseases CPE acts 
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locally by damaging the intestinal epithelium while remaining unabsorbed from the lumen 
(Siarakas et al. 1995, Siarakas et al. 1999). 
 
Veterinary diarrheas 
 
CPE-producing C. perfringens type A has also been linked to diarrheic conditions in several 
animal species, including dogs, pigs, horses, and cows (Wierup 1977, Prescott et al. 1978, 
Wierup and DiPietro 1981, Carman and Lewis 1983, Nabuurs et al. 1983, Collins et al. 1989, 
Estrada-Correa et al. 1989, Kruth et al. 1989, Kanoe et al. 1990, Songer 1996, Marks and 
Kather 2003a, Marks and Kather 2003b, Cave et al. 2002). Moreover, dogs have been 
demonstrated to possess hospital-acquired diarrhea due to cpe-positive C. perfringens (Kruth 
et al. 1989). 
 
2.2.6 Therapeutic use of CPE 
 
Claudin-3 and claudin-4 receptors are highly expressed in several cancer types (Long et al. 
2001, Michl et al. 2001, Kominsky et al. 2004, Nichols et al. 2004, Santin et al. 2007). 
Therefore, the ability of CPE to rapidly and specifically lyse cells expressing claudin-3 and 
claudin-4 may be useful in the treatment of these cancers types (Long et al. 2001, Michl et al. 
2001, Kominsky et al. 2004, Nichols et al. 2004, Santin et al. 2007). In addition to type-
specific therapy for tumors, CPE could aid in drug delivery by being a potent absorption 
enhancer (Ebihara et al. 2006, Kondoh et al. 2006). 
 
2.3 Diagnostics of cpe-positive Clostridium perfringens type A 
2.3.1 Culture methods and confirmation tests 
 
C. perfringens is considered relatively easy to isolate. Its short generation time and relatively 
high optimal growth temperature (43-45ºC) facilitate isolation among most competing 
organisms (Smith 1975). The ability of C. perfringens to form heat-resistant spores also 
facilitates isolation since most of the competing organisms are killed by heating (Smith 1975). 
Moreover, the tolerance of C. perfringens for low concentrations of oxygen also offers an 
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advantage (Smith 1975, Labbé 2000). Conventional detection of C. perfringens is based on 
cultivation and isolation of typical colonies from media, following by confirmation of 
colonies with different tests to reveal phenotypic characteristics. Relative resistance to such 
compounds as sodium sulfite, sulfadiazine, polymyxin, neomycin, kanamycin, and 
cycloserine has enabled the development of several media for C. perfringens cultivation and 
isolation, including tryptose-sulfite-cycloserine (TSC) media with or without egg yolk, 
oleandomycin-polymyxin-sulfadiazine-perfringens (OPSP), and blood agar (BA) with 
neomycin (Harmon et al. 1971, Hauschild and Hilsheimer 1974a, Hauschild and Hilsheimer 
1974b, Hauschild et al. 1974, Labbé 2000). Observation of nitrate reduction, gelatine 
liquefaction, lactose fermentation, or lack of motility in suspected C. perfringens isolates is 
usually sufficient to distinguish C. perfringens from other organisms (Cato et al. 1986). 
Identification of C. perfringens may be also accomplished using commercial biochemical test 
kits such as API (Labbé 2000). Several international method standards are available for 
confirmation of C. perfringens in different samples, including methods published by the 
Association of Official Analytical Chemists (AOAC), the International Standardization 
Organization (ISO), and the Nordic Committee on Food Analysis (NCFA). 
 
2.3.2 Sporulation of Clostridium perfringens and detection of CPE 
 
CPE is synthesized during sporulation, and thus, sporulation in vitro is essential to measure 
the production of CPE of an isolate. Several sporulation media have been devised for 
sporulation of C. perfringens (Ellner 1956, Kim et al. 1967, Duncan and Strong 1968, 
Taniguti 1968, Nishida et al. 1969, Sacks and Thompson 1978, Tortora 1984, Tortora and 
Costa 1985, Harmon and Kautter 1986, Meyer and Tholozan 1999). However, reproducible 
sporulation of C. perfringens is challenging, depending on both the strain and the medium 
used (Labbé 1989). Replacement of starch with raffinose has been found to improve the 
sporulation in some strains (Labbé and Rey 1979). Also addition of caffeine, theophylline, or 
theobromine can increase spore yields in certain strains (Labbé and Nolan 1981, Sacks and 
Thompson 1975, Sacks and Thompson 1977, Sacks and Thompson 1978, Lane and 
Philadelphia 1993). Historically, cooked meat has been the predominant medium applied 
(Labbé 1989), and due to the spore-producing characteristics of this medium, it is often used 
for preparing stock cultures of C. perfringens. Today, modified Duncan Strong medium is 
perhaps most commonly used in sporulating C. perfringens (Lund et al. 2000). The medium 
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contains protease peptone, yeast extract, sodium thioglycollate, sodium hydrogenphosphate 
(Na2HPO4), and raffinose. 
 
The classic way to detect CPE is by observing morphological changes in rabbit ileum in the 
rabbit ileal loop test (Duncan et al. 1968). Guinea-pig skin test, mouse test, and Vero cell 
assay are other biological methods for detecting CPE (Mahony et al. 1989, McDonel and 
McClane 1981). Serological methods are based on using monoclonal or polyclonal antibodies. 
The first serological methods involved microslide single- or double-gel diffusion 
(Genigeorgis et al. 1973, Tortora and Costa 1985), counterimmunoelectrophoresis (Naik and 
Duncan 1977) and electroimmunodiffusion (Duncan and Somers 1972). In these assays, 
detection of CPE is based on observing a precipitation line between CPE and the 
corresponding antiserum. Reverse passive hemagglutination has also been used (Uemura et 
al. 1973). Flow cytometry has been used as an aid to detect cytotoxic activity of CPE (Hu et 
al. 1995, Kusunoki et al. 1998). A widely used technique, with a number of assays available, 
is the enzyme-linked immunosorbent assay (ELISA) (Olsvik et al. 1982, McClane and 
Strouse 1984, Notermans et al. 1984, Bartholomew et al. 1985, Jackson et al. 1985, Jackson 
et al. 1986a, Wimsatt et al. 1986, Berry et al. 1988, Mehta et al. 1989, Piyankarage et al. 
1999). Methods based on immunomagnetic separation (IMS) and ELISA as well as 
chemiluminescent enzyme immunoassay (EIA) have also been reported (Cudjoe et al. 1991, 
Baez et al. 1996). A kit based on reverse passive latex agglutination (RPLA) is extremely 
popular since it provides a straightforward method for detection of CPE from clinical samples 
(Berry and Stringer 1985, Berry et al. 1986, Berry et al. 1988). Western immunoblotting 
offers a highly specific serologic assay for CPE detection, identifying the 35-kDa CPE using 
antibodies prepared against purified CPE (Kokai-Kun et al. 1994). However, this method is 
laborious and is thus primarily used for research purposes. 
 
In general, serological methods have largely replaced biological methods in detecting CPE, as 
they are usually considered more sensitive in detecting low numbers of CPE (Petit et al. 1999, 
Robinson et al. 2000). Some of these methods achieve a sensitivity within the nanogram 
range, whereas biological methods are usually within the microgram range. 
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2.3.3 Detection of cpe 
 
The early methods for detecting cpe were based on DNA hybridization using a probe specific 
for cpe or parts of the gene (Van Damme-Jongsten et al. 1990, Kokai-Kun et al. 1994, Daube 
et al. 1996, Tschirdewahn et al. 1991). Several polymerase chain reaction (PCR) methods 
have since been established (Table 4). These methods amplify cpe from total bacterial DNA 
or bacterial cell lysate or directly from clinical or food samples. Other methods, such as DNA 
microarray, have also been reported in detecting cpe and other toxin genes (Al-Khaldi et al. 
2004a, Al-Khaldi et al. 2004b). Colony hybridization has been used to detect cpe in raw beef 
(Baez and Juneja 1995). 
 
Table 4. PCR methods to detect cpe gene alone or in combination with other toxin genes. 
 
Gene(s) 
detected 
 
 
Specimen(s) 
 
Application 
 
Reference 
 
cpe 
 
Bacterial cell lysate, DNA 
 
Single PCR 
 
(Kokai-Kun et al. 1994, Ridell et al. 
1998) 
 Feces Single PCR (Saito et al. 1992) 
 Meat, feces Nested PCR (Miwa et al. 1996) 
 Intestinal contents MPN-PCR (Miwa et al. 1997) 
 Various foods Single PCR (Kim et al. 2000) 
 Meat PCR-ELISA (Baez et al. 1996) 
 
cpe, cpa 
 
Bacterial cell lysate, DNA 
 
Duplex PCR 
 
(Tansuphasiri 2001,  Augustynowicz et 
al. 2002) 
 Food, feces Duplex PCR (Fach and Popoff 1997) 
 Feces, intestinal contents Duplex PCR (Kanakaraj et al. 1998) 
 Feces Duplex PCR (Tansuphasiri et al. 2002) 
 Water, food, stool samples Real-time FRET-
PCR
 
(Cruz et al. 2006)  
 
 
cpe, cpa, cpb, 
etx, ia 
 
Bacterial cell lysate, DNA 
 
Multiplex PCR 
 
(Daube et al. 1994, Songer and Meer 
1996, Meer and Songer 1997, Kadra et 
al. 1999, Kalender et al. 2005)  
 
cpe, cpa, cpb, 
etx, ia, cpb2 
 
Bacterial cell lysate, DNA Multiplex PCR (Herholz et al. 1999, Garmory et al. 
2000, Gkiourtzidis et al. 2001, Baums 
et al. 2004) 
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2.3.4 Molecular typing of Clostridium perfringens 
 
Typing is the assessment of the relatedness of a group of bacterial isolates, aimed at 
determining whether or not they originate from a common source (Tenover et al. 1995). 
Several typing systems, based on either phenotypic or genotypic characteristics of the 
organism, have been applied in typing C. perfringens (Table 5). Traditionally, serotyping has 
been used as an epidemiological tool in the investigation of C. perfringens food poisoning 
outbreaks, (Hauschild 1975, Lund et al. 2000). Currently, the most commonly used typing 
method in epidemiological studies of C. perfringens is perhaps pulsed-field gel 
electrophoresis (PFGE) (Table 5), being highly reproducible and discriminatory (Schwartz 
and Cantor 1984, Tenover et al. 1997). However, in some cases, PFGE has been unable to 
characterize isolates of C. perfringens or other Clostridia due to degradation of DNA by 
DNAses (Kato et al. 1994, Wada et al. 1996, Hielm et al. 1998, Schalch et al. 2003). 
Recently, PCR genotyping assays have been also developed to detect different IS elements 
attached to cpe, and thus, to establish whether cpe-positive C. perfringens type A isolates 
carry chromosomal or plasmid-borne cpe (Wen et al. 2003, Miyamoto et al. 2004). 
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Table 5. Typing methods used for determining the relatedness of Clostridium perfringens isolates obtained from 
humans, animals, and foods.  
 
Typing method 
 
 
Reference(s) 
 
Bacteriocin typing 
 
(Mahony 1974, Mahony and Swantee 1978, Satija and Narayan 1980, 
Watson et al. 1982, Watson 1985, Mahony et al. 1992, Higa et al. 1991, 
Schalch et al. 1998)  
 
Serotyping 
 
(Hughes et al. 1976, Stringer et al. 1980, Thomas and Noah 1977, 
Chakrabarty and Narayan 1979, Smart et al. 1979, Gross et al. 1989) 
 
Phage typing 
 
(Yan 1989) 
 
Plasmid profile typing 
 
(Mahony et al. 1987, Jones et al. 1989, Mahony et al. 1992, Eisgruber et 
al. 1995, Eisgruber et al. 1996, Schalch et al. 1998, Schalch et al. 1999) 
 
Ribotyping 
 
(Forsblom et al. 1995, Schalch et al. 1997, Schalch et al. 1998, Kilic et 
al. 2002, Manteca et al. 2002, Schalch et al. 2003)  
 
Pulsed-field gel electrophoresis 
typing (PFGE) 
 
(Wada et al. 1996, Collie et al. 1998, Ridell et al. 1998, Maslanka et al. 
1999, Lukinmaa et al. 2002, Bangsberg et al. 2002, Pituch et al. 2002, 
Engstrom et al. 2003, Lin and Labbé 2003, Nauerby et al. 2003, 
Nakamura et al. 2003, Schalch et al. 2003, Fukao et al. 2004, Sobel et al. 
2005, Gholamiandekhordi et al. 2006, Johansson et al. 2006) 
 
Multilocus sequence typing 
(MLST) 
 
(Jost et al. 2006) 
 
Multilocus enzyme typing 
 
(Pons et al. 1994) 
 
Multilocus variable-number 
tandem repeat analysis 
(MLVNTR) 
 
(Sawires and Songer 2005) 
 
Randomly amplified 
polymorphic DNA (RAPD) 
 
(Leflon-Guibout et al. 1997) 
 
Repetitive element PCR (rep-
PCR) 
 
(Siragusa et al. 2006) 
 
Amplified fragment length 
polymorphism (AFLP) 
 
 
(McLauchlin et al. 2000, McLauchlin et al. 2002, Settings 2006) 
 
 
2.4 Epidemiology of cpe-positive Clostridium perfringens type A 
 
Since meat and poultry products are the most common vehicles of C. perfringens type A food 
poisoning, contamination of the meat by the intestinal contents of slaughtered animals might 
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serve an important source of this pathogen to the food supply (Labbé 2000, Heredia and 
Labbé 2001). However, because C. perfringens spores are ubiquitously distributed, the 
contamination might also occur elsewhere in the food chain (McClane 2001). Despite wide 
dispersion of C. perfringens, CPE-producing isolates are only occasionally isolated. These 
have been estimated to represent less than 5% of global C. perfringens isolates (Smedley et 
al. 2004) (Table 6). Thus, the reservoirs for cpe-positive C. perfringens type A are not 
currently understood, and no clear picture has emerged regarding the transmission routes of 
cpe-positive C. perfringens type A isolates to the food chain.  
 
Recent findings of the variable loci (plasmid vs. chromosome) and different genetic 
arrangements adjacent to cpe have shown that cpe-positive isolates form different 
subpopulations. These different subpopulations have been found to be responsible for 
different CPE-associated diseases; chromosomal cpe-bearing strains are involved in food 
poisonings, whereas strains carrying cpe in the plasmid are typical in antibiotic-associated or 
sporadic diarrhea cases as well as in animal diarrheas (Cornillot et al. 1995, Katayama et al. 
1996, Collie and McClane 1998, Sparks et al. 2001). Reasons for the strong disease-genotype 
relationship have been elucidated. C. perfringens strains carrying chromosomal cpe have been 
found to be more resistant to heating, osmotic stress, and low temperatures than plasmid-
borne cpe-carrying strains (Sarker et al. 2000, Li and McClane 2006a, Li and McClane 
2006b), and thus, their presence in retail foods (Wen and McClane 2004) and their 
predominance in food poisonings (Smedley et al. 2004) are understandable. Chromosomal 
cpe strains may gain access to foods more easily and take advantage of temperature abuse 
more effectively than strains with plasmid-borne cpe. Although the disease-genotype 
relationship has been described in several studies, no research has been conducted to elucidate 
the reservoirs for different genotypes. 
Table 6. Prevalence of cpe-positive Clostridium perfringens in healthy animals, humans, foods, and the environment. 
 
Sample 
 
 
 
Number of 
samples 
studied 
 
Number of  
C. perfringens 
isolates 
studied 
 
 
Prevalence of 
cpe-positive  
C. perfringens 
in samples 
(%) 
 
 
Prevalence of 
total  
C. perfringens 
in samples 
(%) 
 
Detection method
a 
 
Country 
 
Reference 
 
Feces or intestines 
 
Calves 
 
21
b 
 
NK
c 
 
10 
 
NK 
 
ELISA 
 
France 
 
(de Rycke et al. 1986) 
 Cats 8 NK 0 50 RPLA, PCR Germany (Werdeling et al. 1991) 
  22
b
 171 1
 
NK CH Belgium (Daube et al. 1996) 
 Cattle
 
51
b
 35 0 49 RPLA Japan (Saito 1990) 
  50 0 26 76 MPN- nested PCR Japan (Miwa et al. 1997) 
  10 0 10 NK Nested PCR Japan (Miwa et al. 1996) 
  50
b
 NK 22 36 Dot blot Switzerland (Tschirdewahn et al. 1991) 
  390
b 
1443 0.4
d 
NK CH Belgium (Daube et al. 1996) 
 Dogs 39 NK 2
b 
54 RPLA, PCR Germany (Werdeling et al. 1991) 
 
 
106
b 
134 2  98 RPLA Japan (Saito 1990)
 
  35 200 3
b 
NK CH Belgium (Daube et al. 1996) 
  16 77 13 NK CH Belgium (Daube et al. 1996) 
 Fowl
 
76
b
 11 0 14 RPLA Japan (Saito 1990) 
  50 0 40 80 MPN- nested PCR Japan (Miwa et al. 1997) 
  59
b
 NK 10 80 Dot blot Switzerland (Tschirdewahn et al. 1991) 
  40 42 0
b 
NK CH Belgium (Daube et al. 1996) 
 Goats 20 55 4
b 
NK CH Belgium (Daube et al. 1996) 
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 Horses 50
b
 NK 14 24 Dot blot Switzerland (Tschirdewahn et al. 1991) 
 Humans
 
80
b
 55 6 57 RPLA Japan (Saito 1990) 
  35 NK 31 NK RPHA Japan (Uemura 1978) 
  46 224 6
b 
NK CH Belgium (Daube et al. 1996) 
  200 225 7 63 Dot blot Mexico (Vela et al. 1999) 
 Reindeer 166 98 2 59 PCR Norway (Aschfalk et al. 2002) 
 Sheep 194 61 0 31 PCR Turkey (Kalender et al. 2005) 
  63 219 2
b 
NK CH Belgium (Daube et al. 1996) 
 Swine 358 62 0 25 PCR USA (Kanakaraj et al. 1998) 
  131
b
 88 0 55 RPLA Japan (Saito 1990) 
  50 0 22 44 MPN- nested PCR Japan (Miwa et al. 1997) 
  10 0 0 NK nested PCR Japan (Miwa et al. 1996) 
  50
b 
NK 0 2 Dot blot Switzerland (Tschirdewahn et al. 1991) 
  48
b 
63 2
b 
NK CH Belgium (Daube et al. 1996) 
Meat (raw) Beef 50 0 2 16 MPN-PCR Japan (Miwa et al. 1998) 
  10 0 0 NK Nested PCR Japan (Miwa et al. 1996) 
 Pork 50 0 0 10 MPN-PCR Japan (Miwa et al. 1998) 
  10 0 0 NK PCR Japan (Miwa et al. 1996) 
 Chicken 50 0 12 84 MPN-PCR Japan (Miwa et al. 1998) 
Meat (processed) Sausage 75 NK 8
b 
NK RPLA Costa Rica (Morera et al. 1999) 
  315 83 2.5 26 RPLA, PCR Argentina (Virginia et al. 2002) 
 Hamburger 100 19 0 19 RPLA, PCR Argentina (Virginia et al. 2002) 
 Minced meat 100 24 1 24 RPLA, PCR Argentina (Virginia et al. 2002) 
Retail food Animal origin 900 NK 1.4 31 PCR USA (Wen and McClane 2004) 
 Animal and 
nonanimal origin 
131 NK 0 30 PCR USA (Lin and Labbé 2003) 
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Spices Various different 
origins 
115 14 3 12 RPLA, PCR Argentina (Aguilera et al. 2005) 
  380 188 4
b 
NK Dot blot Mexico (Rodriguez-Romo et al. 1998) 
 Curry roux 60 NK 0 12 RPLA Japan (Fujisawa et al. 2001) 
Swine feed  60 0 0 48 PCR USA (Kanakaraj et al. 1998) 
Miscellaneous
 
Animals and 
humans, animal 
and human food, 
unknown origin
a
 
NK 616
a 
8
b
 NK PCR USA and 
Canada 
(Songer and Meer 1996) 
 Animals and 
humans, animal 
food, unknown 
origin 
NK 454 4 NK PCR USA (Kokai-Kun et al. 1994) 
         
 
a
 Detection methods: ELISA, enzyme-linked immunosorbent assay; RPLA, reversed passive latex agglutination; PCR, polymerase chain reaction; CH, colony hybridization; 
MPN-nested PCR, nested PCR combined with the most probable number technique; RPHA, reversed passive hemagglutination. 
b 
Some of the studied samples associated with diseases. 
c
 NK, not known. 
d 
Prevalence of cpe-positive isolates among studied C. perfringens isolates.
3. AIMS OF THE STUDY 
 
Studies I-V aimed to develop diagnostics and to investigate the molecular epidemiology of 
cpe-positive C. perfringens type A. Specific aims were as follows: 
 
1. To develop a method for detection, enumeration, and isolation of cpe-positive C. 
perfringens spores from feces (I). 
 
2. To establish a multiplex polymerase chain reaction assay for toxinotyping C. perfringens 
isolates by modifying a previously published protocol (II). 
 
3. To develop an amplified fragment length polymorphism protocol for typing C. perfringens 
isolates and for distinguishing C. perfringens isolates from isolates of other Clostridia species 
(III). 
 
4. To examine the molecular epidemiology of cpe-positive C. perfringens type A by 
elucidating the role of healthy food-handlers as a reservoir and determining the involvement 
of different genotypes of cpe-positive C. perfringens type A in food poisonings (IV and V). 
 
 
35 
 
4. MATERIALS AND METHODS 
 
4.1 Bacterial strains and culturing (I-V) 
 
A total of 11 cpe-positive and 19 cpe-negative C. perfringens strains, 38 strains of other 
clostridia, and nine strains of other bacterial species were included in the development of the 
method for enumeration and isolation of cpe-positive C. perfringens (I). In Study II, a total of 
10 different C. perfringens strains, representing different toxin types, and 15 strains of other 
bacterial species were analyzed, and 118 C. perfringens isolates from broiler chickens were 
evaluated (II, Table 1). In Study III, 129 clostridial strains, 37 of which were C. perfringens 
strains, were used to establish the AFLP protocol (III, Table I). In Study V, a collection of 53 
C. perfringens isolates, 26 from patients and 27 from various foods associated with 11 Finnish 
and 13 German food poisoning outbreaks during 1984-2007, were evaluated (V, Table 1). In 
Studies IV and V, C. perfringens strains NCTC 8239 (type A, cpe-positive), ATCC 3626 
(type B), CCUG 2036 (type C), CCUG 2037 (type D), and CCUG 44727 (type E) were used 
as reference strains. C. perfringens strains were cultivated on blood agar plates and incubated 
at 37ºC for 20-24 h under anaerobic conditions. Other strains were incubated at their optimal 
temperatures and atmospheres. 
 
4.2 Sampling (I and IV) 
 
A total of seven fecal specimens (4 from females and 3 from males) were collected from 
healthy individuals for the development of the enumeration and isolation method (I). The ages 
of these persons varied from 17 to 57 years, and none reported any GI symptoms at the time 
of sampling. In Study IV, fecal specimens of 136 food-handlers (102 females and 34 males) 
were investigated. The specimens were collected in Southern Finland during summer 2003. 
The ages of these persons varied from 15 to 65 years, and none reported any GI symptoms at 
the time of sampling. All specimens were kept at -70ºC prior to use. 
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4.3 DNA extraction (I-V) 
 
In Study I, total DNA from clostridial strains was isolated as described by Hyytiä et al. 
(1999), and from Listeria strains by using the protocol of Keto-Timonen et al. (2005) In 
Studies II, IV, and V, C. perfringens DNA was isolated by using Advamax beads (Edge 
Biosystems, Gaithersburg, MD, USA) according to the manufacturer’s instructions. In Study 
III, the protocol described by Hyytiä et al. (1999) was used, with slight modifications. Strains 
were grown in
 
a tryptose-peptone-glucose-yeast medium (Difco Laboratories,
 
Detroit, MI, 
USA) under anaerobic conditions at the optimal growth
 
temperature for each strain for 14-16 
h. The cells were resuspended
 
in 400 µl of TE (10 mM Tris-HCl, 1 mM EDTA) and incubated
 
with 7.9 mg/ml lysozyme (Sigma, St. Louis, MO, USA), 159 IU/ml mutanolysin
 
(Sigma), and 
476 µg/ml RNase (Sigma) at 37°C with
 
gentle shaking for 15 min (C. botulinum group I), 2 h 
(C. botulinum
 
group II), or 1 h (other Clostridium species). Lysis was completed
 
by adding 52 
µg/ml proteinase K (Finnzymes, Espoo, Finland),
 
0.23 M NaCl, 9.1 mM EDTA, and 0.8% 
(vol/vol) sodium dodecyl
 
sulfate. After thorough mixing, the mixture was incubated at
 
60°C 
for 1 h with gentle shaking. Phenol-chloroform-isoamyl
 
alcohol (25:24:1 [vol/vol]) and 
chloroform-2-pentanol (24:1
 
[vol/vol]) extractions were performed, and the DNA was 
precipitated
 
with ethanol (95% [vol/vol]), rinsed with 70% ethanol, and resuspended
 
 in 100 µl 
of sterile, distilled, deionized water; DNA was
 
stored at –70°C. DNA concentrations were 
determined
 
using a BioPhotometer (Eppendorf, Hamburg, Germany). 
 
4.4 Enumeration and isolation of cpe-positive Clostridium 
perfringens (I) 
4.4.1 cpe-specific probe preparation and sensitivity and specificity 
testing (I) 
 
A 425-bp, DIG-labeled DNA probe, specific for cpe, was prepared by PCR (Miwa et al. 
1996) and labelling kits (High Pure PCR Product Purification Kit, Roche, Mannheim, 
Germany) (DIG High Prime DNA Labeling and Detection Starter Kit I, Roche). The 
sensitivity of the probe was tested as recommended by the manufacturer. The specificity of 
the probe was tested by hybridizing bacterial DNA or pure bacterial cultures. Bacterial DNA 
was spotted on nylon membranes (Roche) and fixed onto membranes using UV crosslinker 
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(Spectroline, Spectronics Corporation, Westbury, NY, USA). Subsequently, the membranes 
were prehybridized at 41°C for 1 h (DIG Easy Hyb, Roche) and hybridized (DIG Easy Hyb 
with 25 ng/ml of denatured probe) overnight at 41°C. Membranes were then washed (2 × SSC 
with 0.1% SDS) and the hybrids were detected with a chromogenic assay using the protocol 
provided by the DIG Application Manual (Roche). 
 
When testing pure bacterial cultures, strains were cultivated on hydrophobic grid membrane 
filters (HGMFs) (Iso-Grid, Neogen, Baltimore, MD, USA), incubated on tryptose-sulfite-
cycloserine (TSC) plates (Shahidi Ferguson perfringens agar, Difco Laboratories, Detroit, MI, 
USA, supplemented with 1% D-cycloserine, Sigma-Aldrich, St. Louis, MO, USA) under 
anaerobic conditions at 37°C for 24 h. Bacterial growth on the HGMF-TSC plates was 
replicated on nylon membranes. The membranes were denatured (0.5 M NaOH, 1.5 M NaCl), 
neutralized (1.0 M Tris-HCl, 1.5 M NaCl, pH 7.4), and air-dried. Exposed DNA was 
subsequently fixed to the membranes as described above. Cell debris was removed using 
proteinase K (Finnzymes, Espoo, Finland) and tightly pressing blotting paper onto the 
membranes. The membranes were thereafter prehybridized and hybridized, washed, and 
stained as described above. 
 
4.4.2 Enumeration and isolation of cpe-positive Clostridium perfringens 
from fecal samples using the hydrophobic grid membrane filter- colony 
hybridization method (I) 
 
A fecal sample (0.1 g) was diluted tenfold in 0.1% peptone water and heated at 75°C for 20 
min and filtered using 10 HGMFs in a membrane filtration system (Iso-Grid, Neogen). 
HGMFs were placed on TSC plates and incubated for 36-42 h at 37°C. Bacterial growth on 
HGMF-TSC agar plates was replicated on nylon membranes, and these replicas were 
hybridized with the DIG-labeled DNA probe as described above with pure bacterial cultures. 
Positive hybridization signals on nylon membranes were enumerated, considered as cpe-
positive colonies on the original HGMF-TSC plate. Nested PCR combined with the MPN 
technique (MPN-PCR) (Oblinger and Koburger 1984) (Miwa et al. 1996) was used as a 
reference to the quantification obtained by the HGMF-CH method. cpe-positive colonies on 
original HGMF-TSC plates were localized by using the nylon membranes. Several probe-
positive colonies were streaked onto blood agar and incubated at 37°C for 24 h. Isolates were 
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further analyzed for the presence of the cpe gene by PCR (Miwa et al. 1996). In Study IV, the 
HGMF-CH method was used for enumeration and isolation of cpe-positive C. perfringens 
from the samples with a positive PCR result for the presence of cpe. 
 
4.5 Multiplex polymerase chain reaction assay (II) 
 
In Study II, the multiplex PCR assay was established by modifying a previously published 
protocol (Meer and Songer 1997). Modification was necessary because when using CPA 
primers of the published protocol, no amplification products were revealed despite several 
optimization attempts and testing with wild and reference C. perfringens strains. The novel 
assay was thus established by designing primers for cpa by using Primer3 program 
(http://www-genome.wi.mit.edu/genome_software/other/primer3.html) (II, Table 2). The 
target sequence was chosen from published DNA sequences of the cpa gene (Tsutsui et al. 
1995, Genbank accession number L43547) 
(http://www.ncbi.nlm.nih.gov/Genbank/index.html). The size of the amplified product was 
adjusted to allow it to be incorporated into the previously published multiplex protocol (Meer 
and Songer 1997). A sequence homology search was performed by using BLAST 
(http://www.ncbi.nlm.nih.gov/blast) to confirm uniqueness of the sequence. The novel assay 
was tested by investigating 118 C. perfringens isolates from Finnish broiler chickens. The 
assay was also used in subsequent studies for toxinotyping and determining the presence of 
cpe in C. perfringens isolates (IV and V). 
 
4.6 Amplified fragment length polymorphism method (III) 
 
The previously used AFLP protocol for C. botulinum strains (Keto-Timonen et al. 2005) was 
applied with some modifications. Total DNA was digested by using a total of 15 U of HindIII 
(New England Biolabs) and 15 U of HpyCH4IV (New England Biolabs) in 1 × One-Phor-All 
buffer plus (Amersham Biosciences, Buckinghamshire, UK), 5 mM dithiothreitol, and 0.1 
mg/ml bovine serum albumin. Restriction site-specific adapters for HindIII (0.04 μM; 
Oligomer, Helsinki, Finland) and HpyCH4IV (0.4 μM; Oligomer) were ligated with 1.1 U T4 
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ligase (New England Biolabs) in 1 × One-Phor-All buffer plus (Amersham Biosciences), 5 
mM dithiothreitol, 0.1 mg/ml bovine serum albumin, and 200 μM ATP. 
 
After digestion and ligation, DNA samples were subjected to preselective PCR using 25 nM 
Hind-0 and 125 nM Hpy-0 primers (Oligomer) (sequences described in Table 2, Study III) in  
a  20-μl reaction mixture also containing 4 μl of diluted template DNA and 15 μl of 
amplification core mix (Applied Biosystems, Foster City, CA, USA). The protocol was as 
follows: 72ºC for 2 min; 20 cycles of 94ºC for 20s, 56ºC for 2 min, and 72ºC for 2 min.   
 
Selective PCR was subsequently done in 10-μl reaction mixtures containing 50 nM 6-
carboxyfluorescein (FAM)-labeled Hind-C primer (Oligomer), 250 nM Hpy-A primer 
(Oligomer), and 7.5 μl of amplification core mix (Applied Biosystems). The following 
protocol was used:  94ºC for 2 min, 1 cycle at 94ºC for 20 s, 66ºC for 30 s, 72ºC for 2 min, 
following by lowering of the temperature by 1ºC each cycle to 56ºC (10 cycles), then 19 
cycles at annealing temperature (56ºC) and a final extension at 60ºC for 30 min. Peltier 
thermal cycler (MJ Research, Inc., Waltham, MA, USA) was used in all PCR reactions.  
 
Internal size standard (0.5 μl) (GS-500 LIZ; Applied Biosystems) and Hi-Di formamide (11.5 
μl) (Applied Biosystems) were mixed with selective amplification products (1 μl) and 
denatured at 95ºC for 2 min. The fragments were electrophoresed on POP-4 polymer (Applied 
Biosystems) on an ABI PRISM 310 Genetic analyzer (Applied Biosystems)in 1 × genetic 
analyzer buffer with EDTA (Applied Biosystems). The electrophoresis was done with 15 kV 
at 60ºC for 28 min. Data was preprocessed with Genescan 3.7 fragment analysis software 
(Applied Biosystems). AFLP patterns were analyzed using BioNumerics software 4.5 
(Applied Maths, Kortrijk, Belgium). Similarity between patterns was calculated with Pearson 
product-moment correlation coefficient. Clustering and dendrogram construction were 
performed by using the unweighted pair-group method with arithmetic averages. 
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4.7 Detection of cpe in enriched samples (IV) 
 
The presence of cpe was determined from enriched samples by using nested PCR (Miwa et al. 
1996) (IV). Two different procedures with sample preparation were used; Samples were 
enriched both after heating the sample at 75ºC for 20 min and without the heating procedure.  
 
4.8 Determination of the location of cpe and presence of different 
insertion sequence elements in cpe-positive Clostridium 
perfringens type A isolates (IV and V) 
 
The locations of cpe and IS elements downstream from cpe (plasmid-borne cpe genotypes 
IS1151-cpe or IS1470-like-cpe and chromosomal cpe genotype IS1470-cpe) in cpe-positive 
C. perfringens type A isolates were determined by PCR using previously described primers 
(Daube et al. 1993, Brynestad 1997, Brynestad et al. 1997, Miyamoto et al. 2002,  Miyamoto 
et al. 2004) and protocols (IV). 
 
4.9 Pulsed-field gel electrophoresis analysis of Clostridium 
perfringens isolates (IV and V) 
 
Restriction enzymes SmaI and ApaI (New England Biolabs, Beverly, MA, USA) were used 
for cleavage of C. perfringens DNA (IV and V). A previously used protocol was applied 
(Ridell et al. 1998), and PFGE profiles were analyzed either visually (V) or both visually and 
with a computer software program (Bionumerics, version 4.5; Applied Maths, Kortrijk, 
Belgium) (IV). The similarities between macrorestriction patterns (MRPs) were expressed by 
Dice coefficient correlation, and clustering by the unweighted pair-group method with 
arithmetic averages was used to construct a dendrogram. 
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4.10 Detection of CPE (IV and V) 
 
cpe-positive C. perfringens isolates were sporulated in modified Duncan Strong medium 
(Sigma-Aldrich Chemie, Steinheim, Switzerland) (Miwa et al. 2002) (IV and V). Sporulation 
is essential prior to detection of CPE from a cpe-positive C. perfringens isolate, since CPE is 
formed in the cell during sporulation. Successful sporulation was confirmed by phase-contrast 
microscopy, and the culture was sonicated until more than 95% of the spores were free, 
determined by phase-contrast microscopy. 
The cytotoxicity of the supernatant was tested using either Vero cell assay (Sandvig and 
Olsnes 1982) (IV) or reverse passive latex agglutination assay (PET-RPLA Seiken, Denka 
Seiken, Tokyo, Japan) (V). Vero cells were grown in a minimal essential medium (MEM; 
Gibco BRL, Paisley, UK) supplemented with 10% fetal calf serum. The strain was defined as 
producing CPE when the inhibition of protein synthesis of Vero cells was more than 20%. A 
reverse passive latex agglutination assay was conducted according to the instructions of the 
manufacturer. 
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5. RESULTS 
 
5.1 Diagnostics of cpe-positive Clostridium perfringens type A (I-III) 
 
The cpe-specific probe was found to be sensitive and specific when tested with C. perfringens 
DNA and cell lysate. The HGMF-CH method was as sensitive as MPN-PCR when tested with 
fecal samples from healthy individuals. With the aid of the HGMF-CH method, cpe-positive 
C. perfringens type A was successfully enumerated and isolated from fecal samples 
possessing positive hybridization signals. The number of cpe-positive C. perfringens type A 
in these samples varied from 60 to 1500 CFU/g. The detection limit of the method was 
dependent on the ratio of cpe-positive C. perfringens colonies to total C. perfringens growing 
on the HGMF-TSC plate. As each HGMF allows the growth of 1600 bacterial colonies, one 
cpe-positive C. perfringens colony could be detected among 1600 total C. perfringens 
colonies. Thus, when investigating 10 HGMFs, cpe-positive C. perfringens could be isolated 
when the ratio of cpe-positive C. perfringens to total C. perfringens was 6 × 10
-5
 or higher. 
 
When establishing the multiplex PCR for toxinotyping and determining the presence of cpe 
from an isolate, all 10 C. perfringens reference strains yielded expected amplification 
products, and none of the other bacterial species; one C. aerotolerans, seven C. botulinum, 
one C. chauvoei, one C. histolyticum, one C. sporogenes and four Staphylococcus aureus 
isolates yielded PCR products. The PCR products were clearly visible and easily 
distinguishable from each other. The newly designed CPA primers were functional when used 
in both single PCR and multiplex PCR reaction with other primers. All 118 C. perfringens 
isolates possessed the cpa gene, but not cpb, etx, iA, or cpe, signifying that all isolates 
represented C. perfringens type A and were cpe-negative. The assay was further successfully 
used in Studies IV and V in determining the toxinotype (A-E) and carriage of cpe in C. 
perfringens isolates. 
 
AFLP was found to be suitable for the identification of C. perfringens among other 
Clostridium species as well as for typing C. perfringens at the strain level. All C. perfringens 
strains were shown to be typeable by AFLP, and thus, the method overcame the occasional 
problem of extracellular DNase production encountered when typing clostridia isolates. AFLP 
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was highly reproducible, easy-to-perform, and relatively fast method, enabling high 
throughput of samples.  
 
5.2 Role of the healthy food-handler as a reservoir for cpe-positive 
Clostridium perfringens type A (IV) 
 
cpe was detected in the feces of 25 healthy food-handlers (18%). With the HGMF-CH 
method, cpe-positive C. perfringens type A was isolated from 11 of the 23 persons studied. 
The average number of cpe-positive C. perfringens type A and total C. perfringens in these 
samples were 2.5 ×10
2 
CFU/g and 1.8 ×10
4 
CFU/g, respectively. In 10 of 11 individuals, cpe-
negative C. perfringens type A formed a 10- to 1000-fold majority in the C. perfringens 
population. Only cpe-positive C. perfringens type A isolates were recovered from one person. 
 
The prevalence of different genotypes of cpe-positive C. perfringens type A was for plasmid-
borne IS1151-cpe, plasmid-borne IS1470-like-cpe, and chromosomal IS1470-cpe 3.7%, 2.9%, 
and 0.7%, respectively. Previously unknown genotypes were also identified, with a 
prevalence of 1.5%. In PFGE analysis, from one to five C. perfringens isolates with different 
MRPs were found in each person. Three persons carried cpe-positive isolates with two 
different MRPs. In one case, two C. perfringens isolates from the same person shared the 
same MRP, but showed different cpe status; one lacked cpe and the other represented 
plasmid-borne IS1470-like-cpe. When we tested a group of isolates from each MRP, CPE 
production was evident in 89%. 
 
5.3 Involvement of different genotypes of cpe-positive Clostridium 
perfringens type A in food poisoning outbreaks (V) 
 
All 53 C. perfringens isolates from different food poisoning outbreaks were of type A, and 48 
(91%) carried cpe. Relative prevalences of different genotypes in the examined outbreaks 
were 75% for chromosomal IS1470-cpe, 21% for plasmid-borne IS1470-like-cpe, and 4% for 
plasmid-borne IS1511-cpe. Sporulation was successful with 34 (70%) of the investigated 
isolates, and all of these isolates produced CPE. A total of 31 different PFGE patterns were 
observed. 
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6. DISCUSSION 
 
6.1 Development of methods and their suitability for the diagnostics 
and epidemiology of cpe-positive Clostridium perfringens (I-III) 
 
The HGMF-CH method provides an effective tool in the investigation of cpe-positive C. 
perfringens from feces (I). Prior to the development of this method, several detection methods 
for cpe had been reported, but none facilitated the isolation of cpe-positive C. perfringens. 
The main advantage of HGMF-CH is that it allows detection and isolation of cpe-carrying 
colonies among large numbers of cpe-negative C. perfringens. Thus, the method is unaffected 
by the presence of vast numbers of cpe-negative C. perfringens in the samples, which is 
encountered as a frequent problem when screening cpe-positive C. perfringens from nature 
(McClane 2001). The successful use of HGMF-CH in Study IV proved that the method is 
adequate for the detection and isolation of cpe-positive C. perfringens from fecal samples. 
The HGMF-CH method proved invaluable in the isolation of cpe-positive strains since in all 
instances when both cpe-positive and cpe-negative C. perfringens were isolated, the former 
existed as a minority and thus would have been missed by using conventional isolation 
methods. By initially screening the samples for the presence of cpe and by choosing the PCR-
positive samples for HGMF-CH, the costs are reduced and the method is rendered more 
effective. 
 
When developing the method, occasional filtration problems were encountered. Obstruction 
of the filtration apparatus and the membrane could be further avoided by using some sample 
preparation methods prior to filtration. Moreover, diarrheic fecal specimens penetrated the 
filtration apparatus and the filter better than feces of normal consistency. Thus, in addition to 
epidemiological studies, the HGMF-CH method seems to be well suited for the diagnostics of 
diarrheic samples from enteric diseases caused by cpe-positive C. perfringens. 
 
The multiplex PCR established was found to be a suitable tool for toxinotyping C. perfringens 
isolates and for detecting the presence of cpe in these isolates (II). In addition to simultaneous 
detection of different toxin genes, CPA primers may also be employed in a single PCR assay 
using the same amplification conditions. Since CPA is produced by each C. perfringens type 
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(A–E), detecting cpa gene in a single PCR assay could serve as a rapid screening method to 
identify C. perfringens among other bacterial species. The use of CPA primers in a single 
PCR reaction would thus be reasonable when aiming to reduce costs and confirming an 
isolate at the species level.  
 
The AFLP method proved suitable in differentiating C. perfringens at the species
 
level as well 
as in typing
 
C. perfringens isolates at the strain level. AFLP was also highly reproducible, 
relatively fast and
 
easy to use. Moreover, it can be completed within two working days. AFLP 
can serve in the generation of identification libraries. Intriguingly, the
 
method seemed to 
overcome the occasional problem of extracellular
 
DNase production encountered when typing 
C. perfringens by other typing methods, such as PFGE. A drawback of the study was that 
AFLP was unsuitable for differentiating
 
between various toxinotypes (A-E) of C. perfringens. 
However, this is not surprising in view of most of the major toxin genes being located on 
extrachromosomal elements and thus potentially being movable. Therefore, the toxinotype 
change of a C. perfringens isolate is possible with the loss or
 
acquisition of these 
extrachromosomal elements. Finally, our finding of C. perfringens isolates originating from 
the same outbreak showing identical fingerprinting patterns indicates
 
that AFLP is a highly 
discriminative genotyping
 
method and serves as an attractive alternative to PFGE typing in 
epidemiological studies.  
 
6.2 Epidemiology of cpe-positive Clostridium perfringens type A (IV 
and V) 
6.2.1 Healthy food-handler as a reservoir for cpe-positive Clostridium 
perfringens type A (IV) 
 
When investigating the presence of cpe-positive C. perfringens in the feces of healthy food-
handlers, the organism was found to be widely distributed in this ecologic niche, being carried 
by 18% of the population studied. By using the HGMF-CH method, we demonstrated that 
cpe-positive strains are frequently present in human feces in low numbers among dominant 
cpe-negative C. perfringens. The study showed that healthy humans are a rich reservoir for 
cpe-positive C. perfringens type A. The presence of strains representing all identified 
genotypes (plasmid-borne IS1151-cpe, plasmid-borne IS1470-like-cpe, and chromosomal 
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IS1470-cpe) as well as strains carrying previously unrecognized genetic arrangements 
attached to cpe reveals that various different subpopulations of cpe-positive C. perfringens 
type A occur in the human GI tract. This also shows that cpe is widely dispersed in C. 
perfringens strains belonging to human GI microbiota, indicating that CPE production is an 
advantageous trait for C. perfringens in this niche. cpe may be stored in strains kept in low 
numbers and then laterally transferred to other C. perfringens strains when conditions are 
favorable. 
 
The common occurrence of cpe-positive C. perfringens type A in the feces of healthy food-
handlers and the full capacity of these strains to produce CPE indicate that humans handling 
food should be considered a possible source of food contamination. If the low numbers of 
cpe-positive C. perfringens type A strains are transferred to the food and favorable conditions 
occur, strains may multiply in the food and cause food poisoning. The person handling food 
should thus be regarded as a risk factor for spread of cpe-positive C. perfringens type A food 
contamination. 
 
6.2.2 Different genotypes of cpe-positive Clostridium perfringens type A 
in food poisoning outbreaks (V) 
 
Chromosomal cpe-carrying C. perfringens type A isolates have been considered to be the 
causative agent in C. perfringens type A food poisonings, whereas C. perfringens type A 
strains carrying plasmid-borne cpe have been linked with other CPE-associated diarrheas. 
Interestingly, in only 75% of the Finnish and German food poisoning outbreaks, chromosomal 
cpe-carrying C. perfringens type A was the causative agent. Thus, C. perfringens type A 
carrying plasmid-borne cpe was involved in 25% of these food poisonings. Previously, 
plasmid-borne cpe strains have been considered atypical causes of food poisonings (Tanaka et 
al. 2003, Nakamura et al. 2004). These results offer the new data that plasmid-borne cpe 
strains cause a notable proportion of C. perfringens type A food poisoning outbreaks in 
Europe. A recent report suggests that this also seems to be the case in Japan (Tanaka et al. 
2007). Thus, emerging evidence shows that plasmid-borne cpe strains are causing food 
poisonings globally, and that the generally accepted relationship between cpe genotype and 
CPE-associated GI disease is not straightforward. Although chromosomal cpe-carrying C. 
perfringens type A strains seem to be the major cause of C. perfringens type A food 
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poisoning, plasmid-borne cpe-carrying C. perfringens type A strains must also be taken into 
account as an important agent causing this common food poisoning. 
 
It seems also obvious that CPE-associated GI diseases may not be strictly divided into 
foodborne and non-foodborne groups. Antibiotic-associated diarrheas and sporadic diarrheas 
with the causative agent being plasmid-borne cpe-carrying C. perfringens type A have 
previously been termed “non-foodborne CPE-associated diseases” (Collie and McClane 1998, 
Collie et al. 1998, Sparks et al. 2001). Regarding our findings that plasmid-borne cpe-
carrying strains cause a notable proportion of C. perfringens type A food poisoning outbreaks, 
these strains appear to frequently be transferred to the human GI tract with food. Therefore, in 
some antibiotic-associated diarrhea and sporadic diarrhea cases, the origin of the causative 
agent may have been food. Alternatively some of the sporadic diarrheas caused by cpe-
positive C. perfringens type A may have actually been “classical” food poisonings, where 
large numbers of cpe-positive C. perfringens cells are ingested, resulting in CPE production 
and diarrheic symptoms. Regarding the results of our studies, we consider it questionable to 
assess whether diarrhea caused by plasmid-borne cpe-carrying C. perfringens type A is truly 
foodborne or not unless epidemiological studies are conducted. 
 
6.2.3 Epidemiology of cpe-positive Clostridium perfringens type A (IV 
and V) 
 
Chromosomal cpe-carrying strains cause the majority of food poisoning outbreaks worldwide. 
These strains have been shown to possess exceptional resistance to heat, cold, and other 
stresses present in the food processing environment, such as high salt and nitrite concentration 
(Li and McClane 2006). Chromosomal cpe-carrying strains may thus harbor a specific niche 
in the food processing environment, which is also evidenced by the study demonstrating their 
predominance in cold-stored retail foods (Wen and McClane 2004). The survival and 
circulation of these strains may therefore be premised on the survival of vegetative cells and 
spores in foods and in the kitchen environment. 
 
The presence of the chromosomal cpe-carrying strains in the GI tract of healthy humans 
indicates that these strains are frequently present in our environment and also that healthy 
persons handling food may transfer these strains into foods. However, not much is known 
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about what happens to chromosomal cpe-carrying strains when they are defecated and thus 
spread in copious amounts in the environment by the diarrheic person suffering from C. 
perfringens type A food poisoning. The environmental routes of these strains causing food 
poisonings remain to be elucidated. Considering that chromosomal cpe-carrying strains 
survive in colder temperature better than plasmid-borne cpe-carrying strains (Li and McClane 
2006), they might also be able to survive better in sewage conditions and represent 
predominance in that environment compared with plasmid-borne cpe-carrying strains. If these 
chromosomal cpe-carrying strains can survive under the extreme conditions in sewage, they 
could circulate back to the kitchen via environmental contamination or via drinking water. 
 
In support of the theory that chromosomal cpe-carrying strains harbor an environmental 
reservoir is that they have not been related to any diseases other than food poisonings. C. 
perfringens type A food poisoning is thought to be caused by a large bolus of cpe-positive C. 
perfringens type A cells that are perhaps subsequently flushed away (Smedley et al. 2004). 
No evidence exists that chromosomal cpe-carrying strains would are capable of causing 
diseases endogenously in the human GI tract. Moreover, it seems that they could possess an 
environmental reservoir, and by multiplying in the food and producing CPE resulting in 
diarrhea, they would be effectively dispersed in the environment again. Survival in the 
environment would then facilitate these strains gaining re-access to the food chain. 
 
The epidemiology of plasmid-borne cpe-carrying strains may well differ from that of 
chromosomal cpe-carrying strains. If the chromosomal cpe-carrying strains have an 
environmental reservoir, plasmid-borne cpe-carrying C. perfringens type A strains may be  
adapted to the intestinal niche. Plasmid-borne cpe-carrying C. perfringens type A strains have 
been linked to antibiotic-associated diarrhea and sporadic diarrhea as well as to animal 
diarrheas (Cornillot et al. 1995, Katayama et al. 1996, Collie and McClane 1998, Sparks et al. 
2001). Our findings of plasmid-borne cpe-carrying strains being a common causative agent 
also in food poisonings reveal this subgroup of cpe-positive C. perfringens type A to have an 
extremely wide disease repertoire and to possess a major pathogen. In early studies, these 
strains have been referred to more frequently than chromosomal strains in nature (Katayama 
et al. 1996). This may well hold true when considering the wide disease repertoire they cause. 
 
The theory about plasmid-borne cpe-carrying C. perfringens type A strains being adapted to 
the human GI microbiota and chromosomal cpe-carrying strains being environmental strains 
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is strengthened by several findings. Plasmid-borne cpe-carrying C. perfringens type A strains 
have been found to contain also other plasmids, whereas the carriage of plasmids by 
chromosomal cpe-carrying strains is not considered common (Raju and Sarker 2005). In order 
to survive in the gut environment, microbes face great demands to adapt to the host 
immunology and to compete with other organisms. Plasmids are known to carry various genes 
that, for example, assist in rapid colonization in different hosts. Thus, by the means of 
plasmid acquisition, the plasmid-carrying strains may be better adapted and diversified in 
different ecological niches (Daubin et al. 2003). By contrast, the chromosomal cpe-carrying 
C. perfringens strain SM101 has been observed to harbor sequences similar to bacteriocin 
gene clusters; the finding suggested to represent an adaptation for competition and survival in 
complex microbial communities such as in sewage or soil (Myers et al. 2006). 
 
As mentioned earlier, C. perfringens type A food poisoning is typically considered to be 
caused by ingestion of a large bolus of cpe-positive C. perfringens type A cells, being 
subsequently flushed away, with symptoms normally limited to 24 hours. On the contrary, 
antibiotic-associated diarrhea and sporadic diarrhea caused by plasmid-borne cpe-carrying C. 
perfringens type A strains is thought to be caused by low numbers of ingested cells, with the 
diarrheic symptoms differing from that of C. perfringens type A food poisoning by their 
severity and longevity. Older age is a risk factor for antibiotic-associated diarrhea caused by 
cpe-positive C. perfringens type A (Asha et al. 2006). Considering our finding of plasmid-
borne cpe-carrying strains also being capable of causing food poisonings, it would be 
interesting to determine whether the infectious dose, symptomology, and other characteristics 
of the disease are similar in C. perfringens type A food poisoning caused by chromosomal 
and plasmid-borne cpe-carrying strains. Whether elderly people are more susceptible to the 
food poisoning caused by plasmid-borne cpe-carrying strains should also be clarified. As C. 
perfringens type A food poisonings often occur in institutionalized settings, which often 
involve elderly people, it would thus be understandable that these places commonly possess 
C. perfringens type A food poisonings (Smith 1998). Future studies remain to be conducted to 
unravel the epidemiology and routes of different genotypes of cpe-positive C. perfringens 
type A in nature. Determining reservoirs of these strains facilitate understanding of the 
movements of these strains and allows better control and prevention of diseases caused by 
cpe-positive C. perfringens type A. 
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The theory of the movable nature of cpe is further strenghtened by the results of Study IV, 
since multiple strains carrying the same cpe plasmid, as well as isolates possessing the same 
PFGE pattern but different cpe status were found from one individual. The findings indicate a 
loss or acquisition of the cpe plasmid by C. perfringens strains. In conclusion, these findings 
offer evidence of in vivo horizontal transfer of cpe between C. perfringens strains in the 
human GI tract. They also support the theory that AAD or SD caused by cpe-positive C. 
perfringens type A may occur as an endogenous infection, the organism being present in the 
GI tract and thus being capable of causing diseases after exposure to antimicrobial drugs or 
other predisposing factors.  
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7. CONCLUSIONS 
 
1. The HGMF-CH method provides a marked improvement in the investigation of 
cpe-positive C. perfringens from feces. The method allows the detection and 
isolation of cpe-carrying colonies among large numbers of bacterial growth, and 
is thus unaffected by the presence of numerous cpe-negative C. perfringens in 
the samples, which is often a problem when screening cpe-positive C. 
perfringens from nature. 
 
2. The multiplex PCR assay, modified from a previously published protocol, 
provides a specific tool for toxinotyping and determining the presence of cpe 
from C. perfringens isolates. 
 
3. AFLP was suitable for the identification of C. perfringens among other 
Clostridium species as well as for typing C. perfringens at the strain level. The 
AFLP protocol was highly reproducible, easy to perform, and relatively fast, 
enabling high throughput of samples.  
 
4. Although the different genotypes of cpe-positive C. perfringens type A have 
been previously characterized and linked to different diseases in several studies, 
no data have existed about the relative prevalence of these genotypes in different 
niches, such as in the human GI tract. Our studies showed that the healthy 
human is a rich reservoir for cpe-positive C. perfringens type A, carrying all 
previously characterized genotypes as well as cpe-positive C. perfringens type A 
strains with unknown genetic arrangement attached to cpe. The findings indicate 
that humans should be considered a possible source of contamination for C. 
perfringens type A food poisoning. If the low numbers of cpe-positive C. 
perfringens type A strains that are present in the human feces are transferred to 
food and favorable conditions occur, the strains can multiply in the food and 
cause food poisoning. Persons handling foods should thus be regarded as risk 
factors for spread of C. perfringens type A food poisoning. 
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The previously proposed theory of the movable nature of cpe is strengthened by 
the results here since multiple strains carrying the same cpe plasmid as well as 
isolates possessing same PFGE pattern but different cpe status were found in 
one individual. An in vivo loss or acquisition of the cpe plasmid by these C. 
perfringens strains was evident, and the findings therefore support the theory 
that AAD or SD caused by cpe-positive C. perfringens type A may occur as an 
endogenous infection, the organism being present in the GI tract and being 
capable of transferring the cpe plasmid after exposure to predisposing factors. 
 
Plasmid-borne cpe-carrying C. perfringens type A was shown to cause a notable 
proportion of C. perfringens type A food poisoning outbreaks in Europe. 
Therefore, the generally accepted relationship between cpe genotype and CPE-
associated GI disease is not straightforward. In addition to chromosomal cpe-
carrying C. perfringens type A strains, also plasmid-borne cpe-carrying C. 
perfringens type A strains have to be taken into account as an important agent 
causing C. perfringens type A food poisoning. The results also indicate that the 
commonly approved nomination of CPE-associated diseases as non-foodborne 
and foodborne is by definition unclear. Hitherto, CPE-associated diseases, such 
as AAD and SD, with the causative agent being plasmid-borne cpe-carrying C. 
perfringens type A have been named “non-foodborne CPE-associated diseases”. 
Regarding the findings of this work that plasmid-borne cpe-carrying C. 
perfringens type A strains are also frequently transferred to the human GI tract 
with food, it is questionable whether the diarrhea caused by plasmid-borne cpe-
carrying C. perfringens type A is truly non-foodborne without epidemiological 
studies. 
 
In conclusion, chromosomal cpe-carrying strains may harbor a specific niche in 
the food processing environment, whereas plasmid-borne cpe-carrying C. 
perfringens type A strains could be adapted to the intestines. We showed that 
both chromosomal and plasmid-borne cpe-carrying C. perfringens type A strains 
can cause food poisonings, and both may be present in the feces of healthy 
humans. Future studies should unravel whether the epidemiology and routes of 
these different genotypes of cpe-positive C. perfringens type A differ from each 
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other. Improved understanding of the movements of these strains would help to 
better control and prevent associated diseases. 
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